As medtech leaders and innovators, the future looks to. us for ways to continually improve healthcare. While our focus is primarily on improving outcomes, readmission rates, and survival rates for patients dealing with a variety of diagnoses, now is the time to add preventative care to our focal point. If there is a silver lining from the COVID-19 pandemic, it’s the importance of a preventive approach to healthcare and wellness that has been brought to the forefront of our minds.


While there has already been a surge over the past year in wearable devices focusing on vital health metrics (i.e. Fitbit, Apple Watch, and Garmin to name just a few, the future looks to us for ways to continually improve the system, this is the way of the future. New devices are leveling up the game by incorporating both AI and integration with providers to predict – and mitigate – the onset of disease before it begins. Such technology will have a huge impact on our entire healthcare model – reducing overall healthcare costs, hospital visits, mortality, lab tests, and needs for chronic treatments – transitioning it from a reactive system to a proactive one.

It’s time to revisit our current and past technologies and begin reinventing them in ways to predict and prevent disease in the hands of consumers. We need to think beyond the current technology and start thinking about what we can do to predict and prevent disesase within our indications, whether it’s modifying or providing applications to major wearable devices or creating our own fro specific patient subsets.

Medication management devices, especially those allowing for customized medication administration and dosing based on specific biomarkers and vital trends are also predicted to be the next big wave of medtech. Providers having access to real-time patient data can react swiftly to adjustments in treatments, even setting up parameters within an integrated app notifying patients of shifts in medication schedules and dosing before their next scheduled dose.


Enlisting the assistance of seasoned veterans in both the clinical research and market access fields will be vital in analyzing the viability of predictive technology. The right data must not only prove patient benefits, but the overall cost savings to payers and providers.

This is medtech’s time to shine. Let us be your beacon – our team of experts can help you find new ways to innovate current technology, prove its value, and help it brighten the world for patients globally.